SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Inotek Pharmaceuticals Corporation's Novel Glaucoma Candidate, INO-8875, Significantly Reduces Intraocular Pressure in Phase 1/2 Study